Investigating immune-epithelial cells in patients with cystic fibrosis

Investigating immune-epithelial cells in patients with cystic fibrosis - Terrific start up

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52014

Enrollment

Registered

2021-06-25

Start date

2021-08-01

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic fibrosi Mucoviscidosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients (18-70 years) diagnosed wit cystic fibrosis Non-smoking for a minimum of 3 months, including cigarettes, marijuana, cigars, and e-cigarettes/vaping.

Exclusion criteria

Exclusion criteria: Patients with an active or treated malignancy Patients who underwent a lung transplant

Design outcomes

Primary

Measure	Time frame
Detailed characterization of immune and epithelial cells composition as well as functional properties in peripheral blood, sputum/BAL and tissue biopsy samples.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results